Celgene (CELG) Holder Brave Asset Management Trimmed Its Position by $428,330 as Market Valuation Declined; Grassi Investment Management Maintains Holding in Goldman Sachs (GS)

January 2, 2018 - By Hazel Jackson

Brave Asset Management Inc decreased its stake in Celgene Corp (CELG) by 6.83% based on its latest 2017Q3 regulatory filing with the SEC. Brave Asset Management Inc sold 2,954 shares as the company’s stock declined 3.49% while stock markets rallied. The institutional investor held 40,298 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.88 million, down from 43,252 at the end of the previous reported quarter. Brave Asset Management Inc who had been investing in Celgene Corp for a number of months, seems to be less bullish one the $83.92 billion market cap company. The stock increased 2.14% or $2.2284 during the last trading session, reaching $106.5884. About 2.06 million shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since January 2, 2017 and is uptrending. It has outperformed by 0.30% the S&P500.

Grassi Investment Management increased its stake in Goldman Sachs (GS) by 79.44% based on its latest 2017Q3 regulatory filing with the SEC. Grassi Investment Management bought 10,125 shares as the company’s stock declined 13.97% while stock markets rallied. The institutional investor held 22,870 shares of the finance company at the end of 2017Q3, valued at $5.43 million, up from 12,745 at the end of the previous reported quarter. Grassi Investment Management who had been investing in Goldman Sachs for a number of months, seems to be bullish on the $96.00B market cap company. The stock decreased 0.10% or $0.25 during the last trading session, reaching $254.51. About 1.06M shares traded. The Goldman Sachs Group, Inc. (NYSE:GS) has risen 39.23% since January 2, 2017 and is uptrending. It has outperformed by 22.53% the S&P500.

Investors sentiment decreased to 1.17 in Q3 2017. Its down 0.17, from 1.34 in 2017Q2. It worsened, as 44 investors sold CELG shares while 457 reduced holdings. 133 funds opened positions while 451 raised stakes. 603.99 million shares or 0.25% more from 602.51 million shares in 2017Q2 were reported. Hartford Mgmt Inc reported 0.04% in Celgene Corporation (NASDAQ:CELG). Spark Investment Mngmt Lc holds 142,800 shares. Moreover, Griffin Asset has 0.29% invested in Celgene Corporation (NASDAQ:CELG). Woodstock holds 2.74% or 98,530 shares in its portfolio. Aspiriant Limited Liability holds 9,014 shares or 0.11% of its portfolio. Mechanics National Bank & Trust Trust Department holds 1,866 shares. Moreover, Bessemer has 0.01% invested in Celgene Corporation (NASDAQ:CELG) for 15,898 shares. Meiji Yasuda Asset Mgmt holds 45,440 shares or 0.65% of its portfolio. Oppenheimer And reported 155,873 shares. Carret Asset Ltd Com accumulated 0.25% or 10,550 shares. Teewinot Advisers Limited Liability Co has 5.42% invested in Celgene Corporation (NASDAQ:CELG) for 82,709 shares. Hugh Johnson Advsr Ltd Company holds 21,496 shares. Blue Edge Ltd Company invested in 13,342 shares. Montag A & Incorporated holds 0.12% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 7,601 shares. Majedie Asset Mgmt Ltd accumulated 0.4% or 33,681 shares.

Analysts await Celgene Corporation (NASDAQ:CELG) to report earnings on January, 25. They expect $1.75 EPS, up 24.11% or $0.34 from last year’s $1.41 per share. CELG’s profit will be $1.38B for 15.23 P/E if the $1.75 EPS becomes a reality. After $1.78 actual EPS reported by Celgene Corporation for the previous quarter, Wall Street now forecasts -1.69% negative EPS growth.

Among 33 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 2 Sell and 12 Hold. Therefore 58% are positive. Celgene Corporation had 118 analyst reports since July 21, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained the shares of CELG in report on Friday, July 24 with “Buy” rating. As per Thursday, January 7, the company rating was initiated by Suntrust Robinson. The firm has “Market Perform” rating given on Friday, February 5 by Leerink Swann. The firm has “Buy” rating given on Tuesday, August 22 by Cantor Fitzgerald. The rating was maintained by Cowen & Co with “Outperform” on Wednesday, August 12. Canaccord Genuity maintained the shares of CELG in report on Tuesday, June 6 with “Buy” rating. Citigroup maintained it with “Buy” rating and $127 target in Thursday, September 29 report. The firm has “Buy” rating given on Sunday, October 15 by Jefferies. Cowen & Co maintained the stock with “Buy” rating in Tuesday, September 12 report. UBS maintained the stock with “Buy” rating in Friday, July 24 report.

Brave Asset Management Inc, which manages about $193.32 million and $190.54 million US Long portfolio, upped its stake in Duke Energy Corp New (NYSE:DUK) by 4,177 shares to 21,978 shares, valued at $1.84 million in 2017Q3, according to the filing. It also increased its holding in Hca Healthcare Inc (NYSE:HCA) by 4,098 shares in the quarter, for a total of 17,477 shares, and has risen its stake in Disney Walt Co (NYSE:DIS).

Since August 2, 2017, it had 0 buys, and 5 insider sales for $6.27 million activity. KAPLAN GILLA sold $1.01 million worth of stock. 9,250 shares valued at $1.29M were sold by CASEY MICHAEL D on Tuesday, September 5. MARIO ERNEST sold $2.42 million worth of Celgene Corporation (NASDAQ:CELG) on Thursday, August 10.

Among 29 analysts covering Goldman Sachs Group Inc. (NYSE:GS), 13 have Buy rating, 1 Sell and 15 Hold. Therefore 45% are positive. Goldman Sachs Group Inc. had 88 analyst reports since July 21, 2015 according to SRatingsIntel. The company was downgraded on Thursday, October 20 by Guggenheim. As per Friday, December 29, the company rating was upgraded by Vertical Group. Deutsche Bank maintained the stock with “Hold” rating in Wednesday, August 12 report. The stock of The Goldman Sachs Group, Inc. (NYSE:GS) has “Hold” rating given on Thursday, December 21 by Keefe Bruyette & Woods. The company was upgraded on Monday, October 12 by Sandler O’Neill. Zacks downgraded the stock to “Hold” rating in Tuesday, September 22 report. The rating was downgraded by Keefe Bruyette & Woods on Wednesday, July 19 to “Hold”. UBS maintained the stock with “Buy” rating in Friday, January 6 report. On Wednesday, April 19 the stock rating was downgraded by Rafferty to “Hold”. Citigroup downgraded the shares of GS in report on Tuesday, November 8 to “Neutral” rating.

Investors sentiment decreased to 0.75 in Q3 2017. Its down 0.33, from 1.08 in 2017Q2. It dropped, as 63 investors sold GS shares while 427 reduced holdings. 82 funds opened positions while 285 raised stakes. 271.74 million shares or 2.47% less from 278.62 million shares in 2017Q2 were reported. National Bank & Trust Of The Ozarks, Arkansas-based fund reported 3,798 shares. Natixis Asset has invested 0.08% in The Goldman Sachs Group, Inc. (NYSE:GS). Atria Invests Lc, North Carolina-based fund reported 5,277 shares. Canada Pension Plan Board holds 780,264 shares. Birinyi reported 18,575 shares. Grantham Mayo Van Otterloo & Ltd Llc has 0% invested in The Goldman Sachs Group, Inc. (NYSE:GS). Howe Rusling has invested 0.03% in The Goldman Sachs Group, Inc. (NYSE:GS). 18,025 were accumulated by Narwhal Capital Mngmt. 17,765 were reported by Arrow Financial Corp. Ifc Inc Fl holds 1,385 shares. Intll invested 0.09% of its portfolio in The Goldman Sachs Group, Inc. (NYSE:GS). Qci Asset Mgmt Ny has invested 1.51% in The Goldman Sachs Group, Inc. (NYSE:GS). Hermes Limited holds 2,014 shares or 0.01% of its portfolio. United Kingdom-based Ahl Prtn Llp has invested 0.04% in The Goldman Sachs Group, Inc. (NYSE:GS). Asset Management Of Georgia Ga Adv has 1,105 shares for 0.19% of their portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts